Published in Eur Heart J on March 01, 2001
Screening for drug-induced (acquired) long QT syndrome: is it time to apply new methods? Eur Heart J (2001) 0.75
AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation (1996) 3.00
Cardiac conduction defects associate with mutations in SCN5A. Nat Genet (1999) 2.73
Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation (2001) 2.65
Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation (2010) 2.53
Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol (1995) 2.42
Functional beta3-adrenoceptor in the human heart. J Clin Invest (1996) 2.32
Aneurysms and pseudoaneurysms of saphenous vein coronary artery bypass grafts. Heart (1998) 2.24
Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem (1998) 1.98
The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J (2000) 1.92
Two types of transient outward currents in adult human atrial cells. Am J Physiol (1987) 1.73
The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res (2000) 1.70
The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest (1998) 1.66
Genetic manipulation of cardiac K(+) channel function in mice: what have we learned, and where do we go from here? Circ Res (2001) 1.66
Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study. Transplantation (1997) 1.46
Sodium channel blocker tests allow a clear distinction of electrophysiological characteristics and prognosis in patients with a type 2 or 3 Brugada electrocardiogram pattern. Heart Rhythm (2008) 1.39
Potassium accumulation in the globally ischemic mammalian heart. A role for the ATP-sensitive potassium channel. Circ Res (1990) 1.23
Differential expression of KvLQT1 and its regulator IsK in mouse epithelia. Am J Physiol Cell Physiol (2001) 1.16
Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids. J Gene Med (2001) 1.16
Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br J Pharmacol (1999) 1.16
Apparent competition between ATP and the potassium channel opener RP 49356 on ATP-sensitive K+ channels of cardiac myocytes. Mol Pharmacol (1989) 1.15
Interferon-gamma downregulates CFTR gene expression in epithelial cells. Am J Physiol (1994) 1.14
The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome. J Med Genet (2003) 1.13
Surgery for aortic stenosis in elderly patients. A study of surgical risk and predictive factors. Circulation (1994) 1.10
Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation. J Med Genet (2009) 1.09
Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28. Am J Hum Genet (1998) 1.07
AKAP proteins anchor cAMP-dependent protein kinase to KvLQT1/IsK channel complex. Am J Physiol Heart Circ Physiol (2001) 1.06
KvLQT1 potassium channel but not IsK is the molecular target for trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl- chromane. Mol Pharmacol (1997) 1.06
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pflugers Arch (1991) 1.02
Differential expression of KvLQT1 isoforms across the human ventricular wall. Am J Physiol Heart Circ Physiol (2000) 1.01
Divergent expression of delayed rectifier K(+) channel subunits during mouse heart development. Cardiovasc Res (2001) 0.99
A dominant negative isoform of the long QT syndrome 1 gene product. J Biol Chem (1998) 0.99
Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part II: Pharmacological profile. Cardiovasc Res (2001) 0.99
Effects of sulphonylureas on cAMP-stimulated Cl- transport via the cystic fibrosis gene product in human epithelial cells. Pflugers Arch (1994) 0.99
Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists. J Pharmacol Exp Ther (1999) 0.98
Characteristics of the time-dependent slow inward current in adult human atrial single myocytes. J Mol Cell Cardiol (1986) 0.98
The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening. J Med Genet (2009) 0.96
Vasomotor dysfunction early after exposure of normal rabbit arteries to an adenoviral vector. Hum Gene Ther (1997) 0.96
Age-related changes of action potential plateau shape in isolated human atrial fibers. Am J Physiol (1985) 0.94
Non-invasive testing of acquired long QT syndrome: evidence for multiple arrhythmogenic substrates. Cardiovasc Res (2001) 0.94
Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part I: Phenotypic characterisation. Cardiovasc Res (2001) 0.94
ATP-binding cassette proteins as targets for drug discovery. Trends Pharmacol Sci (1996) 0.92
Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel. J Pharmacol Exp Ther (2001) 0.92
A hyperpolarization-activated inward current in human myocardial cells. J Mol Cell Cardiol (1992) 0.92
Retrieval of a lost coronary stent from the descending aorta using a PTCA balloon and biopsy forceps. Cathet Cardiovasc Diagn (1993) 0.91
Peripheral tolerance of an allograft in adult rats--characterization by low interleukin-2 and interferon-gamma mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation (1992) 0.90
Adult KCNE1-knockout mice exhibit a mild cardiac cellular phenotype. Biochem Biophys Res Commun (1998) 0.88
Endomyocardial biopsies: a new approach for studying the electrical and mechanical properties of human ventricular myocardium. J Mol Cell Cardiol (1994) 0.88
Mutations in a dominant-negative isoform correlate with phenotype in inherited cardiac arrhythmias. Am J Hum Genet (1999) 0.87
Abnormal cardiac repolarization and impulse initiation in German shepherd dogs with inherited ventricular arrhythmias and sudden death. Cardiovasc Res (1999) 0.87
[Bi-directional ventricular tachycardia and pheochromocytoma: a case report]. Arch Mal Coeur Vaiss (2006) 0.85
Electropharmacological characterization of cardiac repolarization in German shepherd dogs with an inherited syndrome of sudden death: abnormal response to potassium channel blockers. J Am Coll Cardiol (2000) 0.85
Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype. J Thromb Haemost (2007) 0.85
Comparative effects of three class I antiarrhythmic drugs on plateau and pacemaker currents of sheep cardiac Purkinje fibres. Cardiovasc Res (1988) 0.85
A long lasting Ca2+-activated outward current in guinea-pig atrial myocytes. Pflugers Arch (1989) 0.85
Study of a myoglobin test in patients hospitalized for suspected myocardial infarction. Clin Chim Acta (1985) 0.84
Acute simulated ischaemia produces both inhibition and activation of K+ currents in isolated ventricular myocytes. Cardiovasc Res (1996) 0.84
[Legionnaires' disease: 2 case reports]. Nouv Presse Med (1980) 0.83
[Genetic aspects of valvulopathies]. Arch Mal Coeur Vaiss (2007) 0.83
Adenosine A1 stimulation activates delta-protein kinase C in rat ventricular myocytes. Circ Res (1996) 0.83
Do potassium channel openers compete with ATP to activate ATP sensitive potassium channels? Cardiovasc Res (1994) 0.82
1,25 Dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis. J Neuropathol Exp Neurol (1996) 0.82
ATP-sensitive K+ channels regulated by intracellular Ca2+ and phosphorylation in normal (T84) and cystic fibrosis (CFPAC-1) epithelial cells. Pflugers Arch (1995) 0.81
Paramyotonia congenita with an SCN4A mutation affecting cardiac repolarization. Neurology (2003) 0.81
Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: a pilot study. Photodermatol Photoimmunol Photomed (2002) 0.81
Steady-state versus non-steady-state QT-RR relationships in 24-hour Holter recordings. Pacing Clin Electrophysiol (2000) 0.81
LQT genotype-phenotype relationships: patients and patches. Cardiovasc Res (2001) 0.80
Mutation in KCNQ1 that has both recessive and dominant characteristics. J Med Genet (2002) 0.80
Clinical characteristics of a familial inherited myxomatous valvular dystrophy mapped to Xq28. J Am Coll Cardiol (2000) 0.80
Immunoregulation and drug treatment in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Int J Immunopharmacol (1995) 0.80
Expression of CFTR controls cAMP-dependent activation of epithelial K+ currents. Am J Physiol (1996) 0.79
Pentoxifylline inhibits experimental allergic encephalomyelitis. Acta Neurol Scand (1993) 0.79
Concomitant activation of Cl- and K+ currents by secretory stimulation in human epithelial cells. J Physiol (1994) 0.79
Hyperexpression of recombinant CFTR in heterologous cells alters its physiological properties. Am J Physiol (1998) 0.79
Alterations in the force-frequency relationship by tert-butylbenzohydroquinone, a putative SR Ca2+ pump inhibitor, in rabbit and rat ventricular muscle. Br J Pharmacol (1996) 0.78
beta3-adrenoceptor control the cystic fibrosis transmembrane conductance regulator through a cAMP/protein kinase A-independent pathway. J Biol Chem (1999) 0.78
Abnormal subcellular localization of mutated CFTR protein in a cystic fibrosis epithelial cell line. Eur J Cell Biol (1994) 0.78
[Prospective study of the diagnostic and prognostic criteria of right ventricular involvement in the acute phase of inferoposterior infarction]. Arch Mal Coeur Vaiss (1983) 0.78
Patch-clamp study of liver nuclear ionic channels reconstituted into giant proteoliposomes. FEBS Lett (2000) 0.78